Design Therapeutics Inc
XNAS: DSGN
Design Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modify...
Read More
5.53
-0.10
(-1.78%)
106.6K
XNAS Volume
XNAS 22 Oct, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Design Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..